Nicotine administration attenuates methamphetamine-induced novel object recognition deficits

International Journal of Neuropsychopharmacology

Volumn 18, Issue 12, 2015, Pages 1-12

  Vieira Brock, Paula L ^a   McFadden, Lisa M ^a   Nielsen, Shannon M ^a   Smith, Misty D ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Methamphetamine; Nicotine; Nicotinic receptors; Novel object recognition memory; Serotonin transporter

Indexed keywords

DRINKING WATER; METHAMPHETAMINE; NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2; SEROTONIN TRANSPORTER; NICOTINIC AGENT; NICOTINIC RECEPTOR; NOOTROPIC AGENT; SLC6A4 PROTEIN, RAT;

ADOLESCENT; ADULT; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DENTATE GYRUS; DRUG DOSE ESCALATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MALE; MEMORY; NEUROPROTECTION; NONHUMAN; NOVEL OBJECT RECOGNITION DEFICIT; NOVEL OBJECT RECOGNITION TEST; PERIRHINAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; AGING; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; EXPLORATORY BEHAVIOR; GROWTH, DEVELOPMENT AND AGING; MEMORY DISORDERS; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RECOGNITION; SPRAGUE DAWLEY RAT; TEMPORAL LOBE;

ADMINISTRATION, ORAL; AGING; ANIMALS; CA1 REGION, HIPPOCAMPAL; DENTATE GYRUS; DRINKING WATER; EXPLORATORY BEHAVIOR; MALE; MEMORY DISORDERS; METHAMPHETAMINE; NICOTINE; NICOTINIC AGONISTS; NOOTROPIC AGENTS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RECOGNITION (PSYCHOLOGY); SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TEMPORAL LOBE;

EID: 84960465200     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv073     Document Type: Article

References (75)

1. Aleisa AM, Helal G, Alhaider IA, Alzoubi KH, Srivareerat M, Tran TT, Al-Rejaie SS, Alkadhi KA (2011) Acute nicotine treatment prevents REM sleep deprivation-induced learning and memory impairment in rat. Hippocampus 21:899-909.
2. Alkadhi KA (2011) Chronic stress and Alzheimer's disease-like pathogenesis in a rat model: prevention by nicotine. Curr Neuropharmacol 9:587-597.
3. Aznar S, Kostova V, Christiansen SH, Knudsen GM (2005) Alpha 7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum. Synapse 55:196-200.
4. Belcher AM, O'Dell SJ, Marshall JF (2005) Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine-or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30:2026-2034.
5. Belcher AM, Feinstein EM, O'Dell SJ, Marshall JF (2008) Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 33:1453-1463.
6. Bell KA, Shim H, Chen CK, McQuiston AR (2011) Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain alpha4 and beta2 subunits. Neuropharmacology 61:1379-1388.
7. Benowitz NL (1994) Biomarkers of cigarette smoking. In: Smoking and tobacco control monograph 7: The FTC cigarette test method for determining tar, nicotine and carbon monoxide yields of US cigarettes pp 93-111. Bethesda, MD: National Institutes of Health.
8. Besheer J, Bevins RA (2000) The role of environmental familiarization in novel-object preference. Behav Processes 50:19-29.
9. Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
10. Bordia T, Campos C, Huang L, Quik M (2008) Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease. J Pharmacol Exp Ther 327:239-247.
11. Casaletto KB, Obermeit L, Morgan EE, Weber E, Franklin DR, Grant I, Woods SP (2014) Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders. Addict Behav 40c:45-50.
12. Chen CP, Alder JT, Bowen DM, Esiri MM, McDonald B, Hope T, Jobst KA, Francis PT (1996) Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J Neurochem 66:1592-1598.
13. Cherner M, Suarez P, Casey C, Deiss R, Letendre S, Marcotte T, Vaida F, Atkinson JH, Grant I, Heaton RK (2010) Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend 106:154-163.
14. Colloby SJ, Perry EK, Pakrasi S, Pimlott SL, Wyper DJ, McKeith IG, Williams ED, O'Brien JT (2010) Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies. Am J Geriatr Psychiatry 18:86-90.
15. Cucchiaro G, Commons KG (2003) Alpha 4 nicotinic acetylcholine receptor subunit links cholinergic to brainstem monoaminergic neurotransmission. Synapse 49:195-205.
16. Doura MB, Gold AB, Keller AB, Perry DC (2008) Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res 1215:40-52.
17. Fujii S, Ji Z, Morita N, Sumikawa K (1999) Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res 846:137-143.
18. Fujii S, Ji Z, Sumikawa K (2000) Inactivation of alpha7 ACh receptors and activation of non-alpha7 ACh receptors both contribute to long term potentiation induction in the hippocampal CA1 region. Neurosci Lett 286:134-138.
19. Gonzalez R, Rippeth JD, Carey CL, Heaton RK, Moore DJ, Schweinsburg BC, Cherner M, Grant I (2004) Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend 76:181-190.
20. Gould RW, Garg PK, Garg S, Nader MA (2013) Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history. Neuropharmacology 64:479-488.
21. Gould TJ, Portugal GS, Andre JM, Tadman MP, Marks MJ, Kenney JW, Yildirim E, Adoff M (2012) The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation. Neuropharmacology 62:2118-2125.
22. Halff AW, Gomez-Varela D, John D, Berg DK (2014) A novel mechanism for nicotinic potentiation of glutamatergic synapses. J Neurosci 34:2051-2064.
23. Herring NR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT (2008) Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology (Berl) 199:637-650.
24. Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH (2006) Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl) 188:162-170.
25. Huang LZ, Parameswaran N, Bordia T, Michael McIntosh J, Quik M (2009) Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys. J Neurochem 109:826-837.
26. Huang Y, Kandel ER, Levine A (2008) Chronic nicotine exposure induces a long-lasting and pathway-specific facilitation of LTP in the amygdala. Learn Mem 15:603-610.
27. Jia Y, Yamazaki Y, Nakauchi S, Ito K, Sumikawa K (2010) Nicotine facilitates long-term potentiation induction in oriens-lacunosum moleculare cells via Ca2+ entry through non-alpha7 nicotinic acetylcholine receptors. Eur J Neurosci 31:463-476.
28. Johnston LD, O'Malley PM, Miech RA, Bachman JG, Schulenberg JE (2014) Monitoring the future results on adolescent drug use: overview of key findings, 2013. Ann Arbor: Institute for Social Research, The University of Michigan.
29. Jubelt LE, Barr RS, Goff DC, Logvinenko T, Weiss AP, Evins AE (2008) Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacology (Berl) 199:89-98.
30. Kalechstein AD, Newton TF, Green M (2003) Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 15:215-220.
31. Kalechstein AD, De la Garza R 2nd, Newton TF, Green MF, Cook IA, Leuchter AF (2009) Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci 21:254-258.
32. Kalechstein AD, Mahoney JJ 3rd, Verrico CD, De La Garza R 2nd (2014) Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users. Neuropharmacology 85:493-498.
33. Kenney JW, Adoff MD, Wilkinson DS, Gould TJ (2011) The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice. Psychopharmacology (Berl) 217:353-365.
34. King G, Alicata D, Cloak C, Chang L (2010) Neuropsychological deficits in adolescent methamphetamine abusers. Psychopharmacology (Berl) 212:243-249.
35. Kinnavane L, Albasser MM, Aggleton JP (2014) Advances in the behavioural testing and network imaging of rodent recognition memory. Behav Brain Res. doi: 10.1016/j.bbr.2014.07.049.
36. Kruk-Slomka M, Michalak A, Budzynska B, Biala G (2014) A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice. Pharmacol Rep 66:638-646.
37. Lai A, Parameswaran N, Khwaja M, Whiteaker P, Lindstrom JM, Fan H, McIntosh JM, Grady SR, Quik M (2005) Long-term nicotine treatment decreases striatal alpha 6∗nicotinic acetylcholine receptor sites and function in mice. Mol Pharmacol 67:1639-1647.
38. Lawrence JA, Olverman HJ, Shirakawa K, Kelly JS, Butcher SP (1993) Binding of 5-HT1A receptor and 5-HT transporter ligands in rat cortex and hippocampus following cholinergic and serotonergic lesions. Brain Res 612:326-329.
39. Levin ED, Torry D (1996) Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology (Berl) 123:88-97.
40. Levin ED, Wilson W, Rose JE, McEvoy J (1996) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436.
41. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190:269-319.
42. McCabe RT, Gibb JW, Wamsley JK, Hanson GR (1987) Autoradiographic analysis of muscarinic cholinergic and serotonergic receptor alterations following methamphetamine treatment. Brain Res Bull 19:551-557.
43. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J, Ye W, Alexander M, Dannals RF, Wong DF, Ricaurte GA (2008) Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62:91-100.
44. McFadden LM, Hunt MM, Vieira-Brock PL, Muehle J, Nielsen SM, Allen SC, Hanson GR, Fleckenstein AE (2012) Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations. Drug Alcohol Depend.
45. Melichercik AM, Elliott KS, Bianchi C, Ernst SM, Winters BD (2012) Nicotinic receptor activation in perirhinal cortex and hippocampus enhances object memory in rats. Neuropharmacology 62:2096-2105.
46. Meneses A, Perez-Garcia G, Ponce-Lopez T, Tellez R, Castillo C (2011) Serotonin transporter and memory. Neuropharmacology 61:355-363.
47. Mizoguchi H, Ibi D, Takase F, Nagai T, Kamei H, Toth E, Sato J, Takuma K, Yamada K (2011) Nicotine ameliorates impairment of working memory in methamphetamine-treated rats. Behav Brain Res 220:159-163.
48. Nakauchi S, Sumikawa K (2012) Endogenously released ACh and exogenous nicotine differentially facilitate long-term potentiation induction in the hippocampal CA1 region of mice. Eur J Neurosci 35:1381-1395.
49. Newhouse P, Kellar K, Aisen P, White H, Wesnes K, Coderre E, Pfaff A, Wilkins H, Howard D, Levin ED (2012) Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology 78:91-101.
50. North A, Swant J, Salvatore MF, Gamble-George J, Prins P, Butler B, Mittal MK, Heltsley R, Clark JT, Khoshbouei H (2012) Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit. Synapse.
51. O'Dell SJ, Galvez BA, Ball AJ, Marshall JF (2012) Running wheel exercise ameliorates methamphetamine-induced damage to dopamine and serotonin terminals. Synapse 66:71-80.
52. Olivier JD, Jans LA, Korte-Bouws GA, Korte SM, Deen PM, Cools AR, Ellenbroek BA, Blokland A (2008) Acute tryptophan depletion dose dependently impairs object memory in serotonin transporter knockout rats. Psychopharmacology (Berl) 200:243-254.
53. Ouchi Y, Yoshikawa E, Futatsubashi M, Yagi S, Ueki T, Nakamura K (2009) Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease. J Nucl Med 50:1260-1266.
54. Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 289:1545-1552.
55. Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, Haroutunian V, Buxbaum JD, Nasland J, Davis K, Gotti C, Clementi F, Tzartos S, Cohen O, Soreq H, Jaros E, Perry R, Ballard C, McKeith I, Court J (2000) Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur J Pharmacol 393:215-222.
56. Reichel CM, Schwendt M, McGinty JF, Olive MF, See RE (2011) Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 36:782-792.
57. Reichel CM, Ramsey LA, Schwendt M, McGinty JF, See RE (2012) Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 62:1119-1126.
58. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275-297.
59. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N (2006) Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63:90-100.
60. Seth P, Cheeta S, Tucci S, File SE (2002) Nicotinic - serotonergic interactions in brain and behaviour. Pharmacol Biochem Behav 71:795-805.
61. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W (2000) Cognitive impairment in individuals currently using methamphetamine. Am J Addict 9:222-231.
62. Simon SL, Dacey J, Glynn S, Rawson R, Ling W (2004) The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 27:59-66.
63. Sofuoglu M, DeVito EE, Waters AJ, Carroll KM (2013) Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 64:452-463.
64. Soto-Otero R, Mendez-Alvarez E, Hermida-Ameijeiras A, Lopez-Real AM, Labandeira-Garcia JL (2002) Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease. Biochem Pharmacol 64:125-135.
65. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463.
66. Srivareerat M, Tran TT, Salim S, Aleisa AM, Alkadhi KA (2011) Chronic nicotine restores normal Abeta levels and prevents short-term memory and E-LTP impairment in Abeta rat model of Alzheimer's disease. Neurobiol Aging 32:834-844.
67. Swant J, Chirwa S, Stanwood G, Khoshbouei H (2010) Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS One 5:e11382.
68. Tellez R, Rocha L, Castillo C, Meneses A (2010) Autoradiographic study of serotonin transporter during memory formation. Behav Brain Res 212:12-26.
69. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24:6028-6036.
70. Tirelli E, Laviola G, Adriani W (2003) Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci Biobehav Rev 27:163-178.
71. Vorhees CV, Reed TM, Morford LL, Fukumura M, Wood SL, Brown CA, Skelton MR, McCrea AE, Rock SL, Williams MT (2005) Periadolescent rats (P41-50) exhibit increased susceptibility to D-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60). Neurotoxicol Teratol 27:117-134.
72. Welsby PJ, Rowan MJ, Anwyl R (2006) Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus. Eur J Neurosci 24:3109-3118.
73. Welsby PJ, Rowan MJ, Anwyl R (2009) Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus. Eur J Neurosci 29:65-75.
74. Yamazaki Y, Hamaue N, Sumikawa K (2002) Nicotine compensates for the loss of cholinergic function to enhance longterm potentiation induction. Brain Res 946:148-152.
75. Yamazaki Y, Jia Y, Niu R, Sumikawa K (2006) Nicotine exposure in vivo induces long-lasting enhancement of NMDA receptor-mediated currents in the hippocampus. Eur J Neurosci 23:1819-1828.